Now researchers at Case Western Reserve University have developed a method to detect inflammation using antibodies, potentially leading to blood tests for disease-specific biomarkers such as for heart disease, Alzheimer’s disease and various cancers. Their breakthrough also holds promise for drug discovery.

Tissue processing advance can label proteins at the level of individual cells across large samples just as fast and uniformly as in dissociated single cells.

Despite its advantages, laparoscopic surgery remains largely inaccessible in low- and middle-income countries (LMICs) due to the high cost of equipment and other logistical challenges. To bridge this gap, researchers recently developed the KeyScope, an affordable laparoscope designed specifically for LMICs. As reported in Biophotonics Discovery, the KeyScope system was developed through an iterative human-centered design approach.

By age 75, a noteworthy 50% of men develop an inguinal (groin) hernia—a bulge that results from soft tissue pushing through a weak spot in the abdominal muscles. Although common, the cause of these hernias is unknown, and the only treatment is surgery to repair the weakened area. Even after surgery, these hernias recur in 10 to 15% of men.

A DGIST research team, led by Professor Kyung-In Jang, has developed a smart patch capable of real-time biometric signal monitoring and drug delivery. This patch integrates various sensors and a drug delivery system into a single unit using a foldable structure, enabling real-time cardiovascular health monitoring and immediate drug administration when necessary. The research team expects this technology to be widely applicable across multiple medical fields, including glucose management, pain relief, and chronic disease treatment.

Technology is available to assist with nearly every facet of modern life, including helping to prevent people with dementia from wandering and alerting their caregivers when they do.